Published in FEBS Lett on July 03, 2014
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget (2014) 1.22
MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer. PLoS One (2014) 0.99
A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer. J Exp Clin Cancer Res (2015) 0.95
MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5. Oncotarget (2016) 0.83
Regulation of IGF -1 signaling by microRNAs. Front Genet (2015) 0.81
Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis. Br J Cancer (2015) 0.80
Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma. J Hum Genet (2016) 0.79
The role of microRNAs in bladder cancer. Investig Clin Urol (2016) 0.79
Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment. Drug Des Devel Ther (2016) 0.76
MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells. Oncotarget (2016) 0.75
miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling. Oncol Lett (2016) 0.75
Regulation of microRNA during cardiomyocyte maturation in sheep. BMC Genomics (2015) 0.75
A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer. PLoS One (2016) 0.75
MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. Cancer Cell Int (2016) 0.75
Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. Int J Mol Sci (2017) 0.75
Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer. Oncotarget (2017) 0.75
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study. Onco Targets Ther (2017) 0.75
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract (2012) 1.79
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS One (2013) 0.89
Predicting recurrence and progression in Chinese patients with nonmuscle-invasive bladder cancer using EORTC and CUETO scoring models. Urology (2013) 0.87
Robot-assisted laparoscopic resection of large retroperitoneal paraganglioma - initial experience from China. Int J Med Robot (2015) 0.84
Targeted therapy for advanced urothelial cancer of the bladder: where do we stand? Anticancer Agents Med Chem (2012) 0.80
The dual mTORC1 and mTORC2 inhibitor PP242 shows strong antitumor activity in a pheochromocytoma PC12 cell tumor model. Urology (2014) 0.78
Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia. Photomed Laser Surg (2012) 0.77
Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis. Sci Rep (2016) 0.75